Liraglutide, a human GLP-1 analogue, reduces bodyweight in subjects with type 2 diabetes, irrespective of body mass index at baseline Conference Paper uri icon

authors

  • Schmitz, O
  • Russell-Jones, D
  • Shaw, J
  • Brandle, M
  • Matthews, D
  • Frid, A
  • Zdravkovic, M
  • Garber, A
  • Zinman, B

publication date

  • September 1, 2008